© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
NEWS |
Clinical Trial Accrual Efforts: Some Progress Amid Ongoing Debate
| The first 10% of the full text of this article appears below. |
Major new approaches to increasing clinical trial enrollment launched in the past 5 years have produced some early signs of success. Accrual to clinical trials has increased, public awareness and attitudes seem to be improving, and some key trials have accrued much faster than projected.
At the same time, the intensified efforts have cast a spotlight on some fundamental and contentious issues related to accrual. Marketing efforts aimed at the public, for example, are raising ethical concerns, with some researchers questioning whether patients understand the purpose of trials when they sign up. And efforts aimed at increasing physician participation have stirred and heightened a debate about what the optimal system should and could be.
Signs that recruitment efforts may be producing results come from several
Public Awareness Push
Therapeutic Misconception?
Focusing on Physicians
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. T. Hagler and J. W. Lynch Jr Potential Influence of Health Systems in Accrual to Clinical Trials in Lymphoma J. Clin. Oncol., October 1, 2005; 23(28): 7244 - 7245. [Full Text] [PDF]
|
|